HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of International Heart Congress

June 05-07,2025 | Hybrid Event

June 05 -07, 2025 | Rome, Italy
Heart Congress 2025

Cardiovascular outcomes in initial and sustained orthostatic hypotension: A retrospective cohort study

Hui Geng, Speaker at Heart Conferences
Peking University First Hospital, China
Title : Cardiovascular outcomes in initial and sustained orthostatic hypotension: A retrospective cohort study

Abstract:

Classic Orthostatic Hypotension (OH) is a common geriatric disorder and is associated with cardiovascular risk. There are so far too few data available on the prognostic importance of initial OH and the comparison with sustained OH. This study investigated cardiovascular outcomes in initial and sustained OH in a cohort of patients aged>50 years. The study included 435 participants; 94 (21.6%) patients had initial (43, 45.7%) or sustained (51, 54.3%) OH, diagnosed by an active orthostatic test using the CNAP™ monitor. The median follow-up period was 65 months (inter-quartile range, 30 to 71). 159 (36.6%) of the patients had the primary outcome [a composite of major adverse cardiovascular events (MACE) and death from any cause], among which 142 (32.6%) had MACE, and 21 (4.8%) died. Analysis through Kaplan–Meier and further Cox regression models for multivariable adjustment both showed that, initial OH increased both the risk of the primary outcome and MACE (HR 2.20, 95% CI 1.39 to 3.50; HR 2.38, 95%CI 1.48 to 3.84), while didn’t increase the mortality. In contrast, sustained OH increased both the risk of the primary outcome and MACE (HR 1.77, 95% CI 1.17 to 2.69; HR 1.71, 95% CI 1.09 to 2.70), as well as the mortality (HR 3.32, 95% CI 1.29 to 8.50). In conclusion, the preliminary exploration of this relatively small-sample study indicates that, OH, no matter initial or sustained OH, increased the cardiovascular risk in patients aged>50 years, while only sustained OH increased the risk of mortality.

Biography:

Dr. Geng studied Clinical Medicine at Peking University Health Science Center and received her MD degree in 2014. She currently serves as a young physician for the American Heart Association and as a director of the Chinese Hypertension League. She has participated in and led numerous scientific research projects. She has published many research articles in SCI (E) journals and participated in the compilation of multiple books.

Watsapp